The molecular understanding of cytokine signaling has recently advanced due
to new information on knockout animals and patients with mutations, as wel
l as the discovery of inhibitory proteins. Here, Martin Aringer, David M. F
rucht, and John J, O'Shea discuss the developments, focusing on the recepto
rs for interferon-gamma, IL-2, IL-4, and IL-12.